I now have comprehensive material from Robbins covering all major sections. Let me update todos and synthesize the final response.Here is your complete MBBS-level guide to Genetic Disorders, built directly from Robbins & Kumar Pathologic Basis of Disease and Robbins Basic Pathology.
Genetic Disorders — Complete MBBS Guide
1. CLASSIFICATION OF GENETIC DISORDERS
Human genetic disorders fall into four broad categories:
| Category | Mechanism | Examples |
|---|
| Monogenic (Mendelian) | Single gene mutation, high penetrance | Cystic fibrosis, Marfan syndrome, PKU |
| Chromosomal | Numerical or structural chromosome change | Down syndrome, Turner syndrome |
| Complex Multigenic (Multifactorial) | Multiple genes + environment | Atherosclerosis, diabetes, hypertension |
| Somatic mutations | Acquired mutations in non-germline cells | Cancers, clonal hematopoiesis (CHIP) |
"Monogenic disorders are generally rare unless maintained by selective forces, e.g., sickle cell in malaria-endemic areas." — Robbins, Cotran & Kumar Pathologic Basis of Disease
2. MUTATIONS — TYPES AND MECHANISMS
A mutation = any permanent change in DNA sequence. Germline mutations → heritable disease. Somatic mutations → cancer/acquired disorders.
Types of mutations:
| Type | Description | Example |
|---|
| Point mutation (missense) | Single nucleotide change → different amino acid | Sickle cell (Glu→Val in β-globin) |
| Nonsense mutation | Point mutation → premature stop codon → truncated protein | Some CF mutations |
| Silent mutation | Change in codon but same amino acid | Usually no disease |
| Frameshift | Insertion/deletion of non-multiples of 3 nucleotides → scrambled reading frame | Duchenne MD |
| Splice site mutation | Affects intron-exon boundary → aberrant splicing | Thalassemia |
| Trinucleotide repeat expansion | Repeated sequences expand beyond normal range | Fragile X, Huntington's disease |
| Copy number variation (CNV) | Large duplications or deletions | DiGeorge syndrome (22q11.2 del) |
3. INHERITANCE PATTERNS
3.1 Autosomal Dominant (AD)
- One mutant allele sufficient to cause disease
- Every generation affected; 50% of offspring of an affected parent are affected
- Skipping of generations is due to incomplete penetrance or variable expressivity
- Gain-of-function mutations (dominant negative effect) are common
- Examples: Marfan syndrome, Familial hypercholesterolemia (heterozygous), Huntington's disease, Neurofibromatosis type 1 & 2, Achondroplasia, BRCA-related cancers (haploinsufficiency)
3.2 Autosomal Recessive (AR)
- Both alleles must be mutant to cause disease
- Carrier parents (heterozygotes) are phenotypically normal
- 25% of offspring affected; 50% carriers; 25% normal
- Loss-of-function enzyme defects are typically AR
- Examples: Cystic fibrosis, Sickle cell disease, PKU, Tay-Sachs, Niemann-Pick, Gaucher disease, Hurler syndrome
3.3 X-Linked Recessive (XR)
- Males (hemizygous) are almost always affected; females are carriers
- No male-to-male transmission
- Examples: Duchenne/Becker MD, Hemophilia A & B, G6PD deficiency, Hunter syndrome (MPS II), Fragile X (partially)
3.4 X-Linked Dominant (XD)
- Heterozygous females and hemizygous males are affected
- Some are lethal in males (e.g., Incontinentia pigmenti, Rett syndrome)
- Example: X-linked hypophosphatemia (vitamin D-resistant rickets)
3.5 Y-Linked (Holandric)
- Only males; all sons of affected father are affected
- Rare examples: genes on non-pseudoautosomal regions
4. BIOCHEMICAL BASIS OF MENDELIAN DISORDERS
Robbins classifies the mechanisms as:
| Mechanism | Protein Affected | Disease |
|---|
| Structural protein defect | Fibrillin-1 | Marfan syndrome |
| Dystrophin (deletion) | Duchenne/Becker MD |
| Collagen | Osteogenesis imperfecta, EDS |
| Spectrin/ankyrin | Hereditary spherocytosis |
| Receptor/transport defect | LDL receptor | Familial hypercholesterolemia |
| CFTR (Cl⁻/HCO₃⁻ channel) | Cystic fibrosis |
| α/β-globin (structural) | Hemoglobinopathies |
| Enzyme defect | Hex A (α-subunit) | Tay-Sachs |
| Phenylalanine hydroxylase | PKU |
| Glucocerebrosidase | Gaucher disease |
| Sphingomyelinase | Niemann-Pick A&B |
| α-L-iduronidase | Hurler syndrome (MPS I) |
| Lysosomal acid maltase | Pompe disease |
5. KEY SINGLE-GENE (MENDELIAN) DISORDERS
5.1 Marfan Syndrome (AD)
- Gene: FBN1 (fibrillin-1) on chromosome 15q21 → missense mutations
- Fibrillin-1 is a glycoprotein essential for formation of elastic microfibrils (connective tissue scaffold)
- Loss of fibrillin also dysregulates TGF-β signaling (excess TGF-β activity drives many manifestations)
Features (skeletal + ocular + cardiovascular triad):
- Tall stature, long limbs (dolichostenomelia), arachnodactyly, high-arched palate
- Pectus excavatum, scoliosis, joint hypermobility
- Ectopia lentis (upward lens dislocation) — bilateral, pathognomonic
- Cardiovascular (most dangerous): Mitral valve prolapse, cystic medial necrosis of aorta → aortic root dilation, aortic regurgitation, aortic dissection (most common cause of death)
- Thumb sign (Steinberg) and wrist sign (Walker-Murdoch) are clinical clues
5.2 Familial Hypercholesterolemia (AD)
- Gene: LDLR (LDL receptor) on chromosome 19p13 — >2000 mutations known
- Pathogenesis: Defective LDL receptor → impaired uptake of LDL → elevated plasma LDL → atherosclerosis + xanthomas
- Heterozygotes: LDL 2–3× normal → premature atherosclerosis, xanthelasma, tendon xanthomas
- Homozygotes: LDL 5–6× normal → MI in childhood
- Six classes of LDL receptor mutations:
- Class I: No synthesis (null allele)
- Class II: Transport defect (ER accumulation)
- Class III: Ligand-binding defect
- Class IV: Internalization defect (coated pit failure)
- Class V: Recycling defect (receptor trapped in endosome)
- Class VI: Targeting defect (misdirected to apical surface)
- Treatment: Statins (↑LDL receptor synthesis by inhibiting HMG-CoA reductase) + PCSK9 inhibitors (↑LDL receptor by preventing its degradation)
5.3 Cystic Fibrosis (AR)
- Gene: CFTR on chromosome 7q31 — most common mutation is ΔF508 (deletion of phenylalanine at position 508)
- Protein: CFTR = cAMP-regulated Cl⁻/HCO₃⁻ channel in epithelial cells
- Class II mutation (ΔF508) → misfolded CFTR protein → retained in ER → degraded by proteasome
- Pathophysiology: Defective anion transport → thick, dehydrated secretions
- Lungs: Viscid mucus → chronic Pseudomonas/Staphylococcus infections → bronchiectasis, emphysema
- Pancreas: Ductal obstruction → exocrine pancreatic insufficiency, malabsorption, diabetes
- Sweat glands: Elevated sweat Cl⁻ (>60 mEq/L) — diagnostic
- Testes: Bilateral absence of vas deferens → infertility in males
- Diagnosis: Sweat chloride test; CFTR mutation analysis
- New therapy: CFTR modulators (ivacaftor/lumacaftor — for specific mutations)
5.4 Phenylketonuria (AR)
- Gene: PAH (phenylalanine hydroxylase) on chromosome 12q24
- Inability to convert phenylalanine → tyrosine → accumulation of phenylalanine + phenylketones
- Features: Intellectual disability, fair skin, musty odor, eczema, seizures
- Detected by Guthrie test (neonatal heel-prick screening)
- Treatment: Phenylalanine-restricted diet from birth; sapropterin (BH4 cofactor) for some variants
5.5 Lysosomal Storage Diseases
These are AR enzyme deficiencies → substrate accumulates in lysosomes → cellular injury.
| Disease | Enzyme Deficient | Substrate Stored | Key Features |
|---|
| Tay-Sachs | Hexosaminidase A (α-subunit) | GM2 ganglioside | Neurodegeneration, cherry-red spot, death by 2–3 yrs; Ashkenazi Jews |
| Niemann-Pick A/B | Sphingomyelinase | Sphingomyelin | Type A: severe neuro + HSM + death; Type B: no neuro |
| Niemann-Pick C | NPC1/NPC2 (cholesterol transport) | Cholesterol + gangliosides | Ataxia, dysarthria, vertical gaze palsy, psychomotor regression |
| Gaucher disease | Glucocerebrosidase | Glucocerebroside | Gaucher cells (wrinkled tissue paper appearance) in liver/spleen/bone marrow; HSM, bone erosion; Type I most common |
| Hurler syndrome (MPS I) | α-L-iduronidase | Dermatan + heparan sulfate | Coarse facies, corneal clouding, hepatosplenomegaly, coronary deposits, death by 6–10 yrs |
| Hunter syndrome (MPS II) | Iduronate-2-sulfatase | Dermatan + heparan sulfate | X-linked; no corneal clouding; milder course |
| Pompe disease (GSD II) | Acid maltase (lysosomal) | Glycogen | Cardiomegaly, hypotonia, death from cardiac failure in infancy |
Gaucher disease is the most common lysosomal storage disease. It has a strong association with Parkinson disease. Type I is compatible with a long life; enzyme replacement therapy (imiglucerase) is available.
5.6 Glycogen Storage Diseases (GSD)
AR deficiency of glycogen synthesis or degradation enzymes:
| Type | Enzyme | Organ | Features |
|---|
| I (von Gierke) | Glucose-6-phosphatase | Liver, kidney | Hypoglycemia, lactic acidosis, hepatomegaly, hyperlipidemia, "doll-like" face |
| II (Pompe) | Acid maltase | Heart, muscle | Cardiomegaly, hypotonia (infantile); limb-girdle weakness (adult) |
| III (Cori) | Debranching enzyme | Liver, muscle | Milder von Gierke phenotype |
| V (McArdle) | Myophosphorylase | Muscle | Exercise-induced cramps + myoglobinuria; no rise in lactate with exercise |
6. CHROMOSOMAL DISORDERS
6.1 Key Terminology
- Karyotype: Display of metaphase chromosomes (22 autosomes + XX/XY)
- Euploid: Normal multiple of haploid number (23)
- Aneuploid: Abnormal number (not a multiple of 23)
- Trisomy: 47 chromosomes (extra chromosome)
- Monosomy: 45 chromosomes (missing one)
- Nondisjunction: Failure of chromosome separation during meiosis I or II → aneuploidy
- Translocation: Segment of one chromosome attaches to another
- Robertsonian: Long arms of two acrocentric chromosomes fuse (seen in ~4% of Down syndrome)
- Deletion: Loss of chromosomal segment
- Inversion: Segment reverses orientation
6.2 Autosomal Chromosomal Disorders
Trisomy 21 — Down Syndrome (most common chromosomal disorder compatible with life)
| Feature | Detail |
|---|
| Karyotype | 47,XX/XY,+21 (95% nondisjunction); 4% Robertsonian translocation; 1% mosaicism |
| Incidence | 1 in 700 live births overall; 1 in 25 for mothers >45 years |
| Maternal age effect | Strong; 95% of extra chr 21 is of maternal origin |
| Face | Flat facial profile, oblique palpebral fissures (upslanting), epicanthic folds, protruding tongue, single palmar crease (simian crease) |
| Cardiac | 40% have CHD: AVSD (43%) > VSD (32%) > ASD (19%) > Tetralogy of Fallot (6%) — most common cause of death in infancy |
| Neuro | Intellectual disability (IQ usually 25–50); Hypotonia |
| Cancer | 20× ↑ risk of B-ALL; 500× ↑ risk of AML |
| Alzheimer | Virtually all >40 yrs develop Alzheimer neuropathology (APP gene on chr 21) |
| Other | Duodenal/esophageal atresia, Hirschsprung disease, hypothyroidism, atlantoaxial instability |
| Diagnosis | Triple/quadruple screen (↓AFP, ↓uE3, ↑hCG, ↑inhibin A); cell-free fetal DNA; amniocentesis/CVS |
Trisomy 18 — Edwards Syndrome
- Incidence: 1 in 8000; severe intellectual disability; 90% die within 1 year
- Features: Clenched fists with overlapping fingers, rocker-bottom feet, micrognathia, CHD (VSD, PDA), renal malformations, horseshoe kidney
- Prominent occiput
Trisomy 13 — Patau Syndrome
- Incidence: 1 in 15,000; most severe; >80% die within 1 month
- Features: Holoprosencephaly, cyclopia, cleft lip/palate, polydactyly, CHD, microphthalmia, punched-out scalp lesions
22q11.2 Deletion Syndrome (DiGeorge / Velocardiofacial)
- Deletion of chromosome 22q11.2 — most common microdeletion syndrome
- CATCH-22 mnemonic: Cardiac defects (conotruncal), Abnormal facies, Thymic hypoplasia (T-cell deficiency → infections), Cleft palate, Hypocalcemia (parathyroid aplasia)
- Also: schizophrenia risk (1/3 develop psychiatric disorder), learning disabilities
6.3 Sex Chromosome Disorders
Klinefelter Syndrome (47,XXY)
| Feature | Detail |
|---|
| Karyotype | 47,XXY (most common); variants: 48,XXXY; 48,XXYY; 46,XY/47,XXY mosaic |
| Incidence | 1 in 660 male births; most common cause of male hypogonadism |
| Pathogenesis | Extra X inactivated as Barr body, but some X-linked genes escape inactivation |
| Testes | Small, firm testes; hyalinization of seminiferous tubules; azoospermia → infertility |
| Hormones | ↑FSH, ↑LH (↑gonadotropins), ↓testosterone, ↑estradiol |
| Features | Tall stature, eunuchoid build, gynecomastia, sparse body hair, female distribution of body fat |
| Intellect | Usually normal; mild deficits in verbal tasks and executive function |
| Cancer risk | ↑ extragonadal germ cell tumors; ↑ breast cancer |
| Treatment | Testosterone replacement |
Turner Syndrome (45,X)
| Feature | Detail |
|---|
| Karyotype | 45,X (classic); also 46,X,i(Xq); 45,X/46,XX mosaic; 46,XXp- or 46,XXq- |
| Incidence | 1 in 3000 female births; accounts for 1% of spontaneous abortions |
| Pathogenesis | Loss of SHOX gene (Xp22.33) → short stature; accelerated oocyte loss → streak ovaries |
| Features | Short stature (rarely >150 cm), webbed neck, low posterior hairline, wide carrying angle (cubitus valgus), shield chest, widely spaced nipples |
| Ovaries | Streak ovaries → primary amenorrhea (most common cause, 1/3 of cases), infertility |
| Cardiovascular | Bicuspid aortic valve, coarctation of aorta (found in 5% of coarctation diagnoses), aortic root dilation (30%), 100× ↑ risk of aortic dissection |
| Endocrine | Hypothyroidism (50% develop anti-thyroid antibodies), insulin resistance, metabolic syndrome |
| Intellect | Normal IQ but deficits in visual-spatial processing |
| Treatment | Growth hormone; estrogen replacement at puberty |
47,XYY Syndrome
- Males; tall stature; mildly ↓ IQ; behavioral issues; fertile (usually)
- Not associated with increased criminal behavior (old misconception)
47,XXX Syndrome (Triple X)
- Females; usually phenotypically normal; mild learning difficulties; fertile
7. SINGLE-GENE DISORDERS WITH NON-CLASSIC INHERITANCE
7.1 Trinucleotide Repeat Expansion Disorders
In these disorders, normally polymorphic trinucleotide repeats expand beyond a threshold, causing disease. Expansion tends to worsen across generations — anticipation.
| Disease | Gene/Location | Repeat | Normal | Premutation | Full Mutation | Feature |
|---|
| Fragile X | FMR1, Xq27.3 | CGG | <55 | 55–200 | >200 | Methylation silences FMR1 → no FMRP |
| Huntington's | HTT, 4p16.3 | CAG | <36 | 36–39 | >40 | Toxic gain-of-function polyQ protein |
| Myotonic Dystrophy | DMPK, 19q13 | CTG | <37 | — | >50 (up to thousands) | RNA toxic gain-of-function |
| Friedreich's Ataxia | FXN, 9q13 | GAA (intronic) | <33 | — | >100 | Loss of frataxin → mitochondrial iron accumulation |
Fragile X Syndrome (most common inherited cause of intellectual disability)
- Inheritance: X-linked but shows anticipation and maternal transmission bias
- Premutation (55–200 CGG): Mothers are asymptomatic carriers; in male offspring premutation can expand to full mutation
- Full mutation (>200 CGG): Hypermethylation → silencing of FMR1 → loss of FMRP (fragile X mental retardation protein, an RNA-binding protein essential for synaptic development)
- Features in males: Intellectual disability (IQ 20–60), macro-orchidism (large testes), long face with large jaw, large ears, autism-like behaviors
- FXTAS (Fragile X-associated Tremor/Ataxia Syndrome): Premutation carriers (especially males >50 yrs) → cerebellar ataxia, tremor, cognitive decline — gain-of-function RNA toxicity
- FXPOI (Primary Ovarian Insufficiency): Female premutation carriers → early menopause
7.2 Mitochondrial Inheritance
- Mitochondrial DNA (mtDNA) is maternally inherited (all mitochondria come from the egg)
- All children of an affected mother are affected (to variable degrees); no male-to-male transmission
- Heteroplasmy: Cells contain both wild-type and mutant mtDNA → variable expression
- Threshold effect: Disease manifests when mutant mtDNA exceeds a critical proportion in a tissue
- Most affected tissues are highly energy-dependent: brain, skeletal/cardiac muscle, liver, kidneys
Prototype — Leber Hereditary Optic Neuropathy (LHON):
- Mitochondrial gene mutation (most commonly in complex I subunit genes: ND1, ND4, ND6)
- Progressive bilateral loss of central vision, onset ages 15–35
- Also cardiac conduction defects, mild neurological features in some families
Other mitochondrial diseases: MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, Stroke-like episodes), MERRF (Myoclonic Epilepsy with Ragged-Red Fibers), Kearns-Sayre syndrome
7.3 Genomic Imprinting
Definition: Epigenetic silencing of one parental allele (methylation of CpG sites); the gene is expressed from only one parent's copy. Approximately 200–600 genes are imprinted.
- Maternal imprinting = maternal allele silenced → only paternal allele expressed
- Paternal imprinting = paternal allele silenced → only maternal allele expressed
Prader-Willi Syndrome (PWS) vs. Angelman Syndrome (AS) — Same chromosomal region, opposite parents:
| Feature | Prader-Willi Syndrome | Angelman Syndrome |
|---|
| Chromosome deletion | 15q11.2–q13 (paternal deletion) | 15q11.2–q13 (maternal deletion) |
| Mechanism | Loss of paternally expressed genes (SNRPN, etc.) | Loss of maternally expressed UBE3A |
| Intellect | Intellectual disability | Severe intellectual disability |
| Features | Hypotonia at birth, hyperphagia, obesity, small hands/feet, hypogonadism, short stature | Microcephaly, ataxia, seizures, absence of speech, inappropriate laughter ("happy puppet") |
| Other causes | Maternal UPD 15 (2 maternal chr 15); imprinting center defect | Paternal UPD 15; UBE3A point mutation |
Uniparental Disomy (UPD): Both chromosomes of a pair inherited from the same parent → if imprinted genes are involved, this phenocopies deletion syndromes.
7.4 Gonadal Mosaicism
- A germline mutation arises post-fertilization but before germ cell determination → mutation is present in some germ cells but not somatic cells
- Significance: Phenotypically normal parents can have multiple affected children (mimics dominant inheritance skipping generations)
- Important in: osteogenesis imperfecta, Duchenne MD, achondroplasia
7.5 Somatic Mosaicism
- Mutation arises in somatic cells early in development → proportion of affected cells varies
- Results in patchy/asymmetric manifestations
- Example: McCune-Albright syndrome (GNAS activating mutation → fibrous dysplasia, precocious puberty, café-au-lait spots)
8. COMPLEX MULTIGENIC (MULTIFACTORIAL) DISORDERS
- Result from additive effects of multiple susceptibility alleles (each of low penetrance individually) interacting with environmental triggers
- Quantitative traits (height, blood pressure, blood glucose) follow a Gaussian distribution in populations
- Common examples: Type 2 diabetes, hypertension, coronary artery disease, schizophrenia, neural tube defects, cleft lip/palate, pyloric stenosis
- Recurrence risk ∝ severity of disease, number of affected relatives, closeness of relationship
- Carter effect: Males have higher threshold for pyloric stenosis; female probands → higher recurrence risk in relatives (relatives of a lower-risk sex who is affected harbor more susceptibility genes)
9. MOLECULAR DIAGNOSIS OF GENETIC DISORDERS
9.1 Indications for Genetic Testing
Prenatal:
- Advanced maternal age (>34 yrs) → ↑ trisomy risk
- Balanced translocation carrier parent
- Fetal abnormalities on ultrasound / abnormal maternal serum screen
- Previous child with chromosomal/Mendelian disorder
- Carrier of X-linked disorder (to determine fetal sex)
Postnatal:
- Multiple congenital anomalies
- Unexplained intellectual disability/developmental delay
- Suspected aneuploidy (Down, Turner, Klinefelter)
- Infertility
- Recurrent spontaneous abortions
9.2 Key Diagnostic Techniques
| Technique | Use |
|---|
| Karyotyping (G-banding) | Numerical and large structural chromosomal abnormalities |
| FISH (Fluorescence In Situ Hybridization) | Microdeletions (22q11.2), rapid aneuploidy detection (trisomy 21), gene amplification in tumors |
| PCR | Point mutations (sickle cell, CF ΔF508), trinucleotide repeat sizing |
| Array CGH (Comparative Genomic Hybridization) | Genome-wide copy number variations; detects microdeletions/duplications not seen on karyotype |
| SNP arrays | CNVs + UPD detection |
| Next-Generation Sequencing (NGS / WES / WGS) | Comprehensive gene panel testing; rare Mendelian disorders; clinical exome sequencing |
| Cell-free fetal DNA (cfDNA / NIPT) | Non-invasive prenatal screening for trisomies 21, 18, 13 and sex chromosome aneuploidies from maternal blood |
| Sanger sequencing | Confirmation of specific point mutations |
| Methylation analysis | Imprinting disorders (Prader-Willi, Angelman) |
10. QUICK COMPARISON TABLE — HIGH-YIELD MBBS FACTS
| Disorder | Inheritance | Chromosome/Gene | Key Feature | Enzyme/Protein |
|---|
| Marfan syndrome | AD | 15q21 / FBN1 | Ectopia lentis + aortic dissection | Fibrillin-1 |
| Familial hypercholesterolemia | AD | 19p13 / LDLR | Tendon xanthomas, premature MI | LDL receptor |
| Huntington disease | AD | 4p16.3 / HTT | CAG repeats; chorea; anticipation | Huntingtin (polyQ) |
| Neurofibromatosis type 1 | AD | 17q11.2 / NF1 | Café-au-lait, Lisch nodules | Neurofibromin (tumor suppressor) |
| Cystic fibrosis | AR | 7q31 / CFTR | ΔF508; ↑sweat Cl⁻ | CFTR channel |
| PKU | AR | 12q24 / PAH | Intellectual disability; musty odor | Phenylalanine hydroxylase |
| Tay-Sachs | AR | 15q23 / HEXA | Cherry-red spot; Ashkenazi Jews | Hexosaminidase A |
| Gaucher type I | AR | 1q22 / GBA | Gaucher cells; HSM; bone | Glucocerebrosidase |
| Hurler (MPS I) | AR | 4p16 / IDUA | Coarse facies; corneal clouding | α-L-iduronidase |
| Hunter (MPS II) | XR | Xq28 / IDS | Like Hurler but X-linked; NO corneal clouding | Iduronate sulfatase |
| Duchenne MD | XR | Xp21 / DMD | Frame-shift deletion; Gower's sign | Dystrophin |
| Hemophilia A | XR | Xq28 / F8 | Hemarthroses; ↑aPTT | Factor VIII |
| Down syndrome | Chromosomal | Trisomy 21 | Flat face; AV septal defect; leukemia | — |
| Turner syndrome | Chromosomal | 45,X | Primary amenorrhea; coarctation | — |
| Klinefelter | Chromosomal | 47,XXY | Azoospermia; gynecomastia | — |
| DiGeorge (22q11.2 del) | Chromosomal | 22q11.2 deletion | CATCH-22; conotruncal defects; T-cell deficiency | — |
| Fragile X | XD (non-classic) | Xq27.3 / FMR1 | CGG repeats; macro-orchidism | FMRP |
| Prader-Willi | Imprinting | 15q11–q13 (paternal) | Hyperphagia; obesity; hypogonadism | SNRPN/NDN |
| Angelman | Imprinting | 15q11–q13 (maternal) | Seizures; ataxia; inappropriate laughter | UBE3A |
| LHON | Mitochondrial | mtDNA (complex I) | Progressive blindness; maternal inheritance | Complex I |
11. PRENATAL SCREENING SUMMARY
| Test | Timing | Detects |
|---|
| NIPT (cfDNA) | 10+ weeks | Trisomies 21, 18, 13; sex chromosome aneuploidies |
| Nuchal translucency (NT ultrasound) | 11–14 wks | ↑NT → Down syndrome, Turner, cardiac defects |
| First trimester screen (NT + β-hCG + PAPP-A) | 11–13 wks | Trisomy 21 & 18 |
| Quadruple screen | 15–20 wks | ↓AFP, ↓uE3, ↑hCG, ↑inhibin A → Trisomy 21 |
| ↑ maternal AFP | 15–20 wks | Neural tube defects, ventral wall defects |
| Chorionic villus sampling (CVS) | 10–13 wks | Diagnostic karyotype, enzyme assays, DNA |
| Amniocentesis | 15–20 wks | Diagnostic karyotype, AFP (NTD), biochemistry |
12. MNEMONICS FOR QUICK RECALL
- Lysosomal storage diseases → AR (except Hunter = XR)
- CATCH-22 = DiGeorge features (Cardiac, Abnormal facies, Thymic hypoplasia, Cleft palate, Hypocalcemia — chromosome 22)
- Trinucleotide repeats → "GAC" disorders: Grappling with anticipation → CGG (Fragile X), CAG (Huntington, SCA), CTG (Myotonic dystrophy), GAA (Friedreich ataxia)
- Prader-Willi = Paternal deletion (both P's); Angelman = mAternal deletion (A = mAternal)
- Turner syndrome → "Monosomy X" = one X = one shape like "T" upside down → Short stature, Streak ovaries
- Klinefelter = extra X in male → feminizing features (gynecomastia, wide hips) + infertility
*Sources: Robbins, Cotran & Kumar — Pathologic Basis of Disease (10th ed), pp. 83–165 | Robbins & Kumar Basic Pathology (11th ed) | Thompson & Thompson — Genetics and Genomics in Medicine (9th ed)*That is a complete, exam-ready MBBS guide to genetic disorders covering all major curriculum topics. Here's a quick roadmap of what was covered:
What's in this guide:
- Classification — The 4 categories: Monogenic, Chromosomal, Multifactorial, Somatic
- Mutation types — Point, frameshift, splice site, trinucleotide repeats, CNVs
- Inheritance patterns — AD, AR, XR, XD, Y-linked with rules and examples
- Biochemical basis — Structural protein defects, enzyme defects, receptor/transport defects
- Key Mendelian disorders — Marfan, familial hypercholesterolemia (LDL receptor classes I–VI), cystic fibrosis (CFTR/ΔF508), PKU, all lysosomal storage diseases, glycogen storage diseases
- Chromosomal disorders — Trisomy 21, 18, 13; 22q11.2 deletion (DiGeorge/CATCH-22); Klinefelter; Turner; 47,XYY; 47,XXX
- Non-classic inheritance — Trinucleotide repeats (Fragile X, Huntington, myotonic dystrophy, Friedreich); Mitochondrial inheritance (LHON, heteroplasmy, threshold effect); Genomic imprinting (Prader-Willi vs. Angelman); Mosaicism
- Multifactorial disorders — Carter effect, recurrence risk principles
- Molecular diagnostics — Karyotype, FISH, PCR, array CGH, NGS, cfDNA/NIPT
- High-yield tables and mnemonics for quick exam revision